Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
Clinical trial NCT07095127 · RECRUITING
Trial details
- NCT number
- NCT07095127
- Sponsor
- Nuvig Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2027-06-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.